PDE4A and Alzheimer disease: Indeed, the PDE4-specific inhibitor rolipram has been considered as a promising treatment for NDs [249,250], and the PDE4D isoform, involved in the regulation of memory, is found upregulated in AD, suggesting a role in memory loss [251].